CA 19-9 as a predictor of response and survival in patients with pancreatic cancer treated with gemcitabine and cisplatin based chemotherapy

被引：0
|
作者：
Heilbrun, L. K.
Khanna, A.
Venkatramanamoorthy, R.
Shields, A. F.
Philip, P. A.
Zalupski, M. M.
El-Rayes, B. F.
机构：
[1] Karmanos Canc Inst, Detroit, MI USA
[2] Wayne State Univ, Detroit, MI USA
[3] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15094
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Exploiting the relevance of CA 19-9 in pancreatic cancer
    Salleh, Syaza
    Thyagarajan, Anita
    Sahu, Ravi P.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2020, 6
  • [42] Is CA 19-9 useful in the management of pancreatic cancer?
    Balzano, Gianpaolo
    Di Carlo, Valerio
    LANCET ONCOLOGY, 2008, 9 (02): : 89 - 91
  • [43] CA 19-9 and Lewis Antigens in Pancreatic Cancer
    Atkins, Carl D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) : 2572 - 2573
  • [44] Importance of preoperative CA 19-9 Levels in Patients with Localized Pancreatic Cancer Treated with Neoadjuvant Therapy
    Tsai, S.
    Krepline, A.
    Aldakkak, M.
    Ritch, P. S.
    Erickson, B. A.
    Johnston, F.
    Christians, K. K.
    Evans, D. B.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S21 - S21
  • [45] CA 19-9 is an index of response to neoadjunctive chemoradiation therapy in pancreatic cancer
    Willett, CG
    Daly, WJ
    Warshaw, AL
    AMERICAN JOURNAL OF SURGERY, 1996, 172 (04): : 350 - 352
  • [46] Change in CA 19-9 after 8 weeks of first-line chemotherapy as a predictor of overall survival in patients with metastatic pancreatic ductal adenocarcinoma
    Smith, J.
    Florou, V.
    Tan, G.
    Nevala-Plagemann, C.
    Garrido-Laguna, I.
    ANNALS OF ONCOLOGY, 2023, 34 : S16 - S16
  • [47] Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine
    Ziske, C
    Schlie, C
    Gorschlüter, M
    Glasmacher, A
    Mey, U
    Strehl, J
    Sauerbruch, T
    Schmidt-Wolf, IGH
    BRITISH JOURNAL OF CANCER, 2003, 89 (08) : 1413 - 1417
  • [48] Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine
    C Ziske
    C Schlie
    M Gorschlüter
    A Glasmacher
    U Mey
    J Strehl
    T Sauerbruch
    I G H Schmidt-Wolf
    British Journal of Cancer, 2003, 89 : 1413 - 1417
  • [49] The role of Ca 19-9 in progression, recurrence and survival of borderline resectable pancreatic cancer
    Almeida, C.
    Goncalves, M.
    Freitas, M.
    Teixeira, C.
    Couto, M.
    Lemos, T.
    Meireles, S.
    Rego, I.
    Sarmento, C.
    Coelho, A.
    Costa, A.
    Barbosa, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S143 - S144
  • [50] Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704
    Berger, Adam C.
    Garcia, Miguel, Jr.
    Hoffman, John P.
    Regine, William F.
    Abrams, Ross A.
    Safran, Howard
    Konski, Andre
    Benson, Alan B., III
    MacDonald, John
    Willett, Christopher G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (36) : 5918 - 5922
12345